Steven Cohen Biogen Inc. Call Options Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$223.92 - $287.77 $2.24 Million - $2.88 Million
10,000 New
10,000 $2.4 Million
Q2 2020

Aug 14, 2020
SELL
$258.66 - $342.55 $18 Million - $23.8 Million
-69,600 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$268.85 - $341.04 $18.7 Million - $23.7 Million
69,600 New
69,600 $22 Million

Others Institutions Holding BIIB

# of Institutions
1,006
Shares Held
129M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email